CIK 0001776111 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MBX Biosciences, Inc.
Sign in to watch- Ticker
- MBX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 3179893100
- Business address
- 11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,361
- in 2 filings
Net −$288,361. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-12 | Aynechi Tiba Director | Grant or award · Stock Option (Right to Buy) | +15,963 | 15,963 | ||
| 2024-09-12 | Heron Patrick J Director | Grant or award · Stock Option (Right to Buy) | +15,963 | 15,963 | ||
| 2024-09-12 | CORNELIUS JAMES M Director | Grant or award · Stock Option (Right to Buy) | +15,963 | 15,963 | ||
| 2024-09-12 | Pescovitz Ora H. Director | Grant or award · Stock Option (Right to Buy) | +15,963 | 15,963 |
Page 9 of 9 · 164 trades